Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders
Arch Neurol 63:1066-1071, Lehmann,H.C.,et al, 2006
CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997
Present & Initial Clin Course in Pts with CIDP:Comparison of Pts Without & With Monoclonal Gammopathy
Neurol 43:2202-2209, Simmons,Z.,et al, 1993
Cyclosporin A in the Treatment of Chronic Demyelinating Polyradiculoneuropathy
JNNP 53:327-330, Hodgkinson,S.J.,et al, 1990
Treatment of Peripheral Neuropathies
JNNP 48:1193-1207, Hallett,M.,et al, 1985
Clinical Reasoning: A 49-year-old man with Progressive Numbness, Weakness, and Evidence of Leptomeningeal Enhancement
Neurol 90:e90-e93, Lovett, A.,et al, 2018
"Chronic Sensory Demyelinating Neuropathy":CIDP Presenting as a Pure Sensory Neuropathy
JNNP 55:677-680, Oh,S.J.,et al, 1992
A 64-Year-Old Man with Multiple Cranial Neuropathies
Neurol 97:e215-e221, Lefland, A.,et al, 2021
Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 76:294-300, Cortese,I.,et al, 2011
Extraneural Manifestations of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Am J Med 89:531-534, Romanick-Schmiedl,S.,et al, 1990